HIV-associated histoplasmosis in French Guiana: Recent infection or reactivation?

AIDS

Volumn 24, Issue 11, 2010, Pages 1777-1778

  Hanf, Matthieu ^a   Adenis, Antoine ^a   Couppie, Pierre ^b,c   Carme, Bernard ^a,c   Nacher, Mathieu ^a,c,d  

^a Antilles Guyane CIC EC CIE 802   (France)

^b Department of Dermatology ^*  (France)

^c UNIVERSITÉ DES ANTILLES ET DE LA GUYANE   (France)

^d Cayenne General Hospital   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLIMATE CHANGE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FRENCH GUIANA; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; SYSTEMIC MYCOSIS; VIRUS REACTIVATION;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; CLIMATE; EPIDEMIOLOGIC METHODS; FRENCH GUIANA; HISTOPLASMOSIS; HUMANS; RECURRENCE;

EID: 77954349036     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833999c9     Document Type: Article

References (6)

1. Couppie P, Sobesky M, Aznar C, Bichat S, Clyti E, Bissuel F, et al. Histoplasmosis and acquired immunodeficiency syndrome: a study of prognostic factors. Clin Infect Dis 2004; 38:134-138.
2. Wheat LJ. Histoplasmosis: a review for clinicians from non-endemic areas. Mycoses 2006; 49:274-282.
3. Kauffman CA. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 2007; 20:115-132.
4. McKinsey DS, Spiegel RA, Hutwagner L, Stanford J, Driks MR, Brewer J, et al. Prospective study of histoplasmosis in patients infected with human immunodeficiency virus: incidence, risk factors, andpathophysiology. ClinInfectDis 1997; 24:1195-1203.
5. Box G, Jenkins G. Time series analysis: forecasting and control. San Francisco: Holden-Day; 1970.
6. Wheat LJ, Freifeld AG, Kleiman MB, Baddley JW, McKinsey DS, Loyd JE, Kauffman CA. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007; 45:807-825